title: Gastrointestinal toxicities of first and second-generation small molecule human epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer.
authors.affiliation: aSchool of Medicine, University of Adelaide bDivision of Health Sciences, University of South Australia, Adelaide, Australia.
authors.forename: Ysabella Z A
authors.initials: YZ
authors.lastname: Van Sebille
authors.forename: Rachel J
authors.initials: RJ
authors.lastname: Gibson
authors.forename: Hannah R
authors.initials: HR
authors.lastname: Wardill
authors.forename: Joanne M
authors.initials: JM
authors.lastname: Bowen
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D003967:Diarrhea / Q000139:chemically induced*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011799:Quinazolines / Q000009:adverse effects; D052999:Quinazolinones / Q000009:adverse effects
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D052999:Quinazolinones; C525726:dacomitinib; D066246:ErbB Receptors; D000077156:Gefitinib